MedPath

A clinical trial to see the efficacy of angamardaprashamana ghanavati in patients with chronic fatigue syndrome and repetitive stress injury

Phase 2
Conditions
Health Condition 1: PCS-
Registration Number
CTRI/2021/02/031222
Lead Sponsor
Dr Kavya K
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Chronic fatigue syndrome

1. Subjects presenting with classical features of Chronic fatigue syndrome & fulfilling diagnostic criteria.

Repetitive stress injury

1. Subjects using computer >40 hours/ week (Approx.5-6 hours/day)

2. Stage III Repetitive stress injury

3. subjects fulfilling diagnostic criteria.

4. Subjects willing to participate.

Exclusion Criteria

Chronic fatigue syndrome

1. Subjects having any other medical condition explaining fatigue

2. Major depressive disorders (psychotic features) or bipolar disorders.

3. Schizophrenia, dementia or delusional disorders

4. Anorexia nervosa, bulimia nervosa

5. Alcohol or substance abuse

6. Severe obesity (BMI >40)

Repetitive stress injury

1. Any H/O upperlimb fracture

2. Any H/O pathological disorders of upperlimb

3. All regular exercise

4. Subjects with Congenital anomalies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the signs and symptoms of chronic fatigue syndrome and Repetitive stress injuryTimepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
ature and presentation of the disease can be knownTimepoint: 4 weeks
© Copyright 2025. All Rights Reserved by MedPath